Eva Beckett

UT Health San Antonio

PAPER Ti Y, Liu F, Ma Y, Zhu Q, Xie C, Xia H, Chen J

Correlation of Plasma α-Synuclein with Cerebral Blood Flow in Patients with Parkinson Disease with Freezing of Gait.

Clin Lab. 2025 Mar 1;71(3) PubMed.

PAPER Guo JL, Huang TY, Zhang Z, Niu K, Gongbikai X, Gong XL, Wang XM, Zhang T

[The role of microglia activated by the deletion of immune checkpoint receptor CD200R1 gene in a mouse model of Parkinson's disease].

Sheng Li Xue Bao. 2025 Feb 25;77(1):13-24. PubMed.

PAPER Zarnowska A, Milewska M, Rokicka G, Kacprzyk K, Panczyk M, Folwarski M, Szostak-Węgierek D

Prevalence of malnutrition in patients with Alzheimer's disease- A systematic review. The call for consistent nutritional assessment methods.

Nutr Hosp. 2025 Mar 6; Epub 2025 Mar 6 PubMed.

PAPER Li T, Chen J, Xie Z, Fang J, Wu Q, Cao X, Chen Z, Wang Y, Fan Q, Wang Q, Liu J

Ginsenoside Ro ameliorates cognitive impairment and neuroinflammation in APP/PS1 mice via the IBA1/GFAP-MAPK signaling pathway.

Front Pharmacol. 2025;16:1528590. Epub 2025 Feb 24 PubMed.

PAPER Sugimoto T, Uchida K, Sato K, Yokoyama Y, Onoyama A, Fujita K, Kuroda Y, Wakayama S, Arai H, Sakurai T, J‐MINT study group

Factors associated with adherence to tablet-based cognitive training: J-MINT study.

Alzheimers Dement (N Y). 2025;11(1):e70062. Epub 2025 Mar 10 PubMed.

PAPER Cuní-López C, Stewart R, Okano S, Redlich GL, Appleby MW, White AR, Quek H

Exploring a patient-specific in vitro pipeline for stratification and drug response prediction of microglia-based therapeutics.

Sci Rep. 2025 Mar 10;15(1):8296. PubMed.

PAPER Li Z, He Y, Zhang J, Yang J, Cheng J, Zhang X

The changes of NLRs family members in the brain of AD mouse model and AD patients.

Front Immunol. 2025;16:1555124. Epub 2025 Feb 24 PubMed.

PAPER Leuchter MK, Oughli HA, Durbin KA, Jackson NJ, Elashoff D, Chang TS, Corlier J, Ngo D, Matthews C, Wong D, Fogel BL, Bitan G, Leuchter AF, Vossel K, Suthana N

Broad repetitive transcranial magnetic stimulation (rTMS) of the precuneus in Alzheimer's disease: A rationale and study design.

Alzheimers Dement (N Y). 2025;11(1):e70043. Epub 2025 Mar 10 PubMed.

PAPER Liu GS, Song Y, Yan JS, Chai YJ, Zhao YF, Ma H

Identification of enterotype for patients with Alzheimer's disease.

J Transl Med. 2025 Mar 10;23(1):299. PubMed.

PAPER Lv L, Zhang H, Tan J, Wang C

Neuroprotective role and mechanistic insights of DJ-1 dimerization in Parkinson's disease.

Cell Commun Signal. 2025 Mar 10;23(1):129. PubMed.

PAPER Cai Y, Kanyo J, Wilson R, Bathla S, Cardozo PL, Tong L, Qin S, Fuentes LA, Pinheiro-de-Sousa I, Huynh T, Sun L, Mansuri MS, Tian Z, Gan HR, Braker A, Trinh HK, Huttner A, Lam TT, Petsalaki E, Brennand KJ, Nairn AC, Grutzendler J

Subcellular proteomics and iPSC modeling uncover reversible mechanisms of axonal pathology in Alzheimer's disease.

Nat Aging. 2025 Mar 10; Epub 2025 Mar 10 PubMed.

PAPER Bian X, Guo Q, Yau LF, Yang L, Wang X, Zhao S, Wu S, Qin X, Jiang ZH, Li C

Berberine-inspired ionizable lipid for self-structure stabilization and brain targeting delivery of nucleic acid therapeutics.

Nat Commun. 2025 Mar 10;16(1):2368. PubMed.

PAPER Dahiya M, Yadav M, Goyal C, Kumar A

Insulin resistance in Alzheimer's disease: signalling mechanisms and therapeutics strategies.

Inflammopharmacology. 2025 Mar 10; Epub 2025 Mar 10 PubMed.

PAPER Qaisar R, Karim A, Iqbal MS, Alkahtani SA, Ahmad F

Associations of plasma Neurofilament light chain with sarcopenia and physical capacity in patients with Alzheimer's diseases.

Acta Neurol Belg. 2025 Mar 11; Epub 2025 Mar 11 PubMed.